David Préfontaine
AbbVie (United States)(US)ABB (Canada)(CA)
Publications by Year
Research Areas
Asthma and respiratory diseases, IL-33, ST2, and ILC Pathways, Chronic Obstructive Pulmonary Disease (COPD) Research, Respiratory Support and Mechanisms, Dermatology and Skin Diseases
Most-Cited Works
- → TH17-associated cytokines (IL-17A and IL-17F) in severe asthma(2009)620 cited
- → Increased Expression of IL-33 in Severe Asthma: Evidence of Expression by Airway Smooth Muscle Cells(2009)533 cited
- → Increased IL-33 expression by epithelial cells in bronchial asthma(2010)449 cited
- → Cigarette smoke increases TLR4 and TLR9 expression and induces cytokine production from CD8+T cells in chronic obstructive pulmonary disease(2011)88 cited
- → Variability of sputum inflammatory cells in asthmatic patients receiving corticosteroid therapy: A prospective study using multiple samples(2010)72 cited
- → Six Minute Walk Distance Is a Predictor of Survival in Patients with Chronic Obstructive Pulmonary Disease Undergoing Pulmonary Rehabilitation(2015)66 cited
- → Using a Virtual Game System to Innovate Pulmonary Rehabilitation: Safety, Adherence and Enjoyment in Severe Chronic Obstructive Pulmonary Disease(2013)57 cited
- → Epithelium‐derived chemokines induce airway smooth muscle cell migration(2009)41 cited
- → In vitro bioactivity of combustion products from 12 tobacco constituents(2005)25 cited
- → Airway epithelial cells in asthma(2007)24 cited